Former Editas CEO Bosley joins UK venture capital firm
Dive Brief:
Katrine Bosley, the former CEO of gene editing biotech company Editas Medicine, has joined U.K.-based Advent Life Sciences as a venture partner, the in...
From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
Advertisement